Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-24

Clinical Trial Update: An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

View source ↗

Summary

An observational study assessing the safety and effectiveness of MabThera (rituximab) in individuals with severe active rheumatoid arthritis; the study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-10-24